Have You Heard of Harvoni?

The U.S. Food and Drug Administration on 10/10/14 approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.

“Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection. It is also the first approved regimen that does not require administration with interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection.”

Full FDA press release –includes data supporting approval.

Related blog postThe Future is Now (for Hepatitis C) | gutsandgrowth

5 thoughts on “Have You Heard of Harvoni?

  1. Pingback: Telaprevir-Based HCV Therapy is Expensive Too | gutsandgrowth

  2. Pingback: Clinical Science Year in Review in Pediatric GI – NASPGHAN 2014 | gutsandgrowth

  3. Pingback: Financial Relief For Patients with Hepatitis C | gutsandgrowth

  4. Pingback: Hepatitis C : New and Newer Treatments | gutsandgrowth

  5. Pingback: Changing Narrative on Affordability of HCV Treatments | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.